ABOUT US

New Beta Innovation Limited is dedicated to discovery and development of advanced life-saving hemoglobin-based therapeutics for the well-being of people.

Leveraging on our expertise in research and development, we have been transforming drug discovery into clinical applications ...

VIEW MORE
OUR SCIENCE

RESEARCH & DEVELOPMENT
Our research and clinical development focus on the following therapeutic areas:
View Publications
Oncological Disorder
Neurological Disorder
Ischemic Condition

CLINICAL DEVELOPMENT

Phase l Clinical Trial

  • Study Title: YQ23 Study in Patients With Critical Limb Ischaemia
    •  

This is an early phase study to assess how safe and tolerable is the new study drug YQ23 and to compare the effectiveness of YQ23 against normal saline to treat critical limb ischaemia. The study also aims to understand how it affects the body and an optional substudy to assess how the human body takes up, breaks down, and clears the study drug. (Read More...)



  • Study Title: First-In-Man, Healthy Volunteer Study to Evaluate Safety on the Use of YQ23
    •  
  • Completed

This study is to test the safety, tolerability, pharmacokinetics (PK-the amount of study drug in the blood), and immunogenicity (how the study drug affects the immune system) of single dose and dose levels of an investigational drug called YQ23. (Read More...)



  • Study Title: A Safety Study of YQ23 in Advanced Solid Tumors Patients
    •  

This is an early phase dose escalation study which is divided into two stages: (1) single agent of the test drug YQ23, and (2) in combination with pembrolizumab administered to patients with advanced solid tumors. The purpose of the study is to establish the safety and tolerability profile, as well as the maximum tolerated dose (MTD) of YQ23 as a single agent (stage 1) and in combination with pembrolizumab (stage 2). Stage 2 will start only when the MTD of single agent YQ23 has been established in Stage 1. (Read More...)
NEWS
CAREERS

We believe a dedicated, talented, quality-focused work force is a vital asset to the company and fundamental to our success. We are constantly seeking qualified members who are passionate about doing great work to join our team.

We encourage all interested parties to apply for any of the vacancies listed below. We offer a competitive remuneration package, wide-range of training opportunities and career development prospects. If you are eager to create an exciting and rewarding career, please send us your full resume for consideration.

All personal data collected will be treated in strict confidence and will only be used for recruitment purposes. Please read our privacy policy for further information about how we handle personal data in relation to job applications for vacancies in Hong Kong.

COUNTRY
CONTACT US
Your personal data is collected and used by us in accordance with our privacy policy.
I have read and agree to the privacy policy.
Address
18/F, Chevalier Commercial Centre, 8 Wang Hoi Road, Kowloon Bay, Hong Kong
Tel
+852 2133 2688
Fax
+852 2133 2988
Email
info@newbetainnovation.com
AFFILIATED COMPANIES
× We use page tagging techniques and cookies to improve the site, provide services to you, and customize your browsing experience. By continuing to browse the site you are agreeing to accept our use of cookies